Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yingqiao Zhu"'
Autor:
Ziwei Zhou, Erling Chen, Jiqian Jiang, Lei Xue, Lijun Zhu, Xing Hu, Yingqiao Zhu, Changcheng Zheng, Juan Tong
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Introduction: Acute promyelocytic leukemia (APL) is mainly due to the chromosome translocation t(15; 17) (q22; q12), leading to the formation of PML-RARα fusion protein. However, some patients carried rare translocation involving RARα gene, and the
Externí odkaz:
https://doaj.org/article/cf8aa9f34d36426a929aab12132b05a0
Autor:
Fengyan Jin, Huifan Ji, Chunshu Jia, Ulf Brockmeier, Dirk M Hermann, Eric Metzen, Yingqiao Zhu, Baorong Chi
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47161 (2012)
Combination treatment with endostar, a novel modified endostatin, and cytotoxic chemotherapies showed a survival benefit in Chinese clinical trials. However, the exact mechanism for this synergism remains unclear. In this study, we report for the fir
Externí odkaz:
https://doaj.org/article/ac815a1fea9e4b59921ca38c3da93286
Publikováno v:
Advanced Ultrasound in Diagnosis and Therapy, Vol 3, Iss 4, Pp 197-199 (2019)
Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for more than 90% of liver cancers. It results in between 250,000 and 1 million deaths globally per annum. Unlike other cancers, HCC can usually be diagnosed on imaging studie
Externí odkaz:
https://doaj.org/article/b88a2e66252140d89c764cc84a9fc1b8
Autor:
Huijuan Peng, MD, Wenzhao Liang, MD, Lei Liu, MD, Jing Jia, MD, Yingqiao Zhu, Dezhi Zhang, MD
Publikováno v:
Advanced Ultrasound in Diagnosis and Therapy, Vol 3, Iss 3, Pp 132-135 (2019)
Ultrasound (US) has been the most common imaging modality to guide ablation therapy. However, if the tumor is adjacent to intrahepatic bile ducts, only using US as guiding image may not be safe or effective. Gd-EOB-DTPA magnetic resonance imaging (MR
Externí odkaz:
https://doaj.org/article/32427e10debe4fbc8bdbbd37f6b89674
Publikováno v:
Oncology Reports. 46
Multiple myeloma (MM) is a disease with an adverse outcome and new therapeutic strategies are required to combat this disease. It is well known that tumor‑suppressor microRNA (miRNA) acts as a new potential anticancer agent. Accumulating evidence s
Publikováno v:
Advanced Ultrasound in Diagnosis and Therapy, Vol 3, Iss 4, Pp 197-199 (2019)
Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for more than 90% of liver cancers. It results in between 250,000 and 1 million deaths globally per annum. Unlike other cancers, HCC can usually be diagnosed on imaging studie
Autor:
Yanping Yang, Yun Dai, Dehui Zou, Xiao Ding, Qiang Guo, Yi Peng, Wenyang Huang, Yingqiao Zhu, Lugui Qiu, Xuelian Liu, Fengyan Jin, Hongqiong Fan
Publikováno v:
Annals of hematology. 99(6)
Autologous stem cell transplantation (ASCT) is the only curable therapy for multiple myeloma (MM), while its success primarily relies on mobilization to obtain sufficient hematopoietic stem/progenitor cells (HPC). Although the role of Pegfilgrastim (
Autor:
LEI LIU1, YINGQIAO ZHU1 zhuyingqiaoZYQ@163.com, DONGXUAN WANG1, CHANGBIN YANG2, QI ZHANG3, XIUKUN LI4, YANG BAI1
Publikováno v:
Oncology Letters. May2016, Vol. 11 Issue 5, p3303-3307. 5p.
Publikováno v:
Oncology Letters
Gastrointestinal stromal tumors (GIST) are mesenchymal neoplasms of the gastrointestinal tract (GI) that are defined, in part, by the expression of CD117, a c-Kit proto-oncogene protein. GISTs emerge outside of the GI at a very low frequency, typical
Publikováno v:
Oncology Reports
Multiple myeloma (MM) is a disease with an adverse outcome and new therapeutic strategies are required to combat this disease. It is well known that tumor‑suppressor microRNA (miRNA) acts as a new potential anticancer agent. Accumulating evidence s